Multimodality evaluation of excision repair cross-complementation 1 (ERCC1) expression as a predictive biomarker for platinum resistance in epithelial ovarian cancer (EOC).
C. O. Michie
No relevant relationships to disclose
L. Song
No relevant relationships to disclose
D. Faratian
No relevant relationships to disclose
J. Orr
No relevant relationships to disclose
T. Rye
No relevant relationships to disclose
J. Clark
Employment or Leadership Position - MDxHealth
J. M. Bartlett
No relevant relationships to disclose
D. J. Harrison
Consultant or Advisory Role - Response Genetics (U)
Research Funding - Response Genetics
D. Melton
No relevant relationships to disclose
A. Williams
No relevant relationships to disclose
C. Gourley
No relevant relationships to disclose